Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01109433 · ClinicalTrials.gov registry record
Immunogenetic Mechanisms in Behcet's Disease
A clinical trial, sponsored by National Eye Institute (NEI).
- Terminated
- Registry status
- 25
- Enrollment target
NCT01109433 is a clinical trial that was terminated before completion, run by National Eye Institute (NEI). The registered enrollment target is 25 participants.
The verdict
NCT01109433 was terminated before completion, sponsored by National Eye Institute (NEI).
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Background: \- Uveitis, the inflammation of the interior of the eye, is responsible for numerous new cases of legal blindness every year. Uveitis can be caused by Beh(SqrRoot)(Beta)et s disease (BD), a chronic inflammatory disorder that can affect the eye, mucous membranes, and other body organs such as the joints, intestinal tract, blood vessels, and central nervous system. Objectives: The purpose of this study is to see how genes affect Beh(SqrRoot)(Beta)et s disease and if there are differences in Beh(SqrRoot)(Beta)et s disease among people of different backgrounds. Eligibility: * Individuals who have a diagnosis of BD and are enrolled in another NIH study. * Individuals who are willing to donate blood for the purposes of this research study and who are willing to have their blood stored for possible future/other research purposes. Design: * As part of the study, blood samples will be drawn from participants when an exacerbation in disease activity occurs and before and after any significant change in treatment for BD. * No treatments will be provided in this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-04-15 |
| Est. Completion | 2018-12-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01109433
The ClinicalTrials.gov registry entry for NCT01109433 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01109433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01109433 about?
NCT01109433 is a clinical study titled "Immunogenetic Mechanisms in Behcet's Disease". Background: \- Uveitis, the inflammation of the interior of the eye, is responsible for numerous new cases of legal blindness every year. Uveitis can be caused by Beh(SqrRoot)(Beta)et s disease (BD), a chronic inflammatory disorder that can affect the eye, mucous membranes, and other body organs su...
What is the current status of trial NCT01109433?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2010-04-15. Estimated completion is 2018-12-17.
Who is sponsoring clinical trial NCT01109433?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.